1. Matsushita K, Cha EK, Matsumoto K, Baba S, Chromecki TF, Fajkovic H, Sun M, Karakiewicz PI, Scherr DS, Shariat SF (2011) Immunohistochemical biomarkers for bladder cancer prognosis. Int J Urol 18(9):616–629. doi: 10.1111/j.1442-2042.2011.02809.x
2. Shariat SF, Zlotta AR, Ashfaq R, Sagalowsky AI, Lotan Y (2007) Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. Mod Pathol Off J U S Can Acad Pathol Inc 20(4):445–459. doi: 10.1038/modpathol.3800757
3. Przybojewska B, Jagiello A, Jalmuzna P (2000) H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers. Cancer Genet Cytogenet 121(1):73–77
4. Ayan S, Gokce G, Kilicarslan H, Ozdemir O, Yildiz E, Gultekin EY (2001) K-RAS mutation in transitional cell carcinoma of urinary bladder. Int Urol Nephrol 33(2):363–367
5. Vageli D, Kiaris H, Delakas D, Anezinis P, Cranidis A, Spandidos DA (1996) Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors. Cancer Lett 107(2):241–247